https://clinicaltrials.gov/ct2/show/NCT02635945?type=Intr&cond=COPD&phase=01234&lupd_s=10%2F23%2F2018&lupd_d=14&sort=nwst A Study to Assess the Efficacy of a 5-day, 10- mg PBF-680 Oral Administration on Late Asthmatic Responses (LAR) in Mild to Moderate Asthmatic Patients. Condition : Asthma Interventions : Drug: PBF-680; Drug: Placebo Sponsors : Palobiofarma SL; Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau; […]